Veterinary Pain Management Market Outlook and Opportunities in Grooming Regions with Forecast 2032

Market Research Future (MRFR) has published on the “Global Veterinary Pain Management Market”.Veterinary Pain Management market is estimated to register a CAGR of 6.42% during the forecast period of 2024 to 2032.

Veterinary Pain Management Market Highlights

The global veterinary pain management market is accounted to register a CAGR of 6.42% during the forecast period and is estimated to reach USD 3.70 billion by 2032.

Pet ownership in the US has increased dramatically during the last three decades. As of 2023, 66% of US families (86.9 million houses) own a pet. Pets provide invaluable companionship and emotional support to their owners. In fact, 85% of dog owners and 76% of cat owners regard their pets as family members. Furthermore, millennials account for the highest proportion of current pet owners (33%), followed by Generation X (25%), and Baby Boomers (24%). Dogs and cats are the most popular pets in the US, but other animals and types are also popular. Fish, birds, and small animals like as hamsters and rabbits are kept in millions of households. Therefore, the rise in companion animal ownership and large pet population across the globe is expected to support veterinary pain management market growth over the forecast period.

Growing prevalence of painful and inflammatory diseases in animals, rise in companion animal ownership and large pet population and rise in pet insurance with growing animal health expenditure. However, limitations lack of awareness regarding animal health is expected to hamper the growth of the global market. Nevertheless, collaborations of major players with small players are projected to create lucrative opportunities for market players.

Key Players

MRFR recognizes the following companies as the key players in the global veterinary pain management market— Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US), Dechra Pharmaceuticals PLC (Northwich, UK), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), Assisi Animal Health (New Mexico, US), Eltech K-Laser (Treviso, Italy).

Segment Analysis

The global veterinary pain management market has been segmented based on product, animal type, application, distribution channel.

On the basis of product, the global veterinary pain management market is segmented into medication, and devices. The medication segment was attributed to holding the largest market share in 2022 revenue as estimated by MRFR analysts. This is due to the extensive number of companies focusing on the development of NSAIDs and opioids for pain management which is directly pushing the growth of this segment.

Based on animal type, the global veterinary pain management market is segmented into Companion Animals, and Livestock Animals. The Companion Animals segment was expected to hold the largest market share in 2022. The is due to the rising ownership of pets which is projected to fuel the growth of the segment.

Based on application, the global veterinary pain management market is segmented into Joint Pain, Postoperative Pain, Cancer, and Others. The Joint Pain segment was expected to hold the largest market share in 2022. The is due to the increasing cases of musculoskeletal disorders in animals and is set to drive the growth of this segment.

Based on Distribution Channel, the global veterinary pain management market is segmented into Veterinary Hospitals & Clinics, Pharmacies, and Online Pharmacies. The Veterinary Hospitals & Clinics segment was expected to hold the largest market share in 2022. The is due to the increasing uptake and adoption rate of this distribution channel which is anticipated to drive the growth of this segment.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Veterinary Pain Management Market Research Report

Regional Analysis

The global veterinary pain management market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. North America consists of US and Canada. The Europe veterinary pain management market comprises Germany, France, the UK, Italy, Spain, and the rest of Europe. The veterinary pain management market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the world’s veterinary pain management market comprises of Middle East, Africa, and Latin America.  

Rising health expenditure per person and increasing demand for advanced technologies are driving the growth of the veterinary pain management market in North America. Furthermore, the presence of a large number of noticeable players such as Elanco (Indiana, US), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), and Assisi Animal Health (New Mexico, US), in this region is the major driving factor of the market.

Moreover, the Europe market has been persistently growing owing to the increased focus on the health & well-being of animals is driving the demand for pain management products in the region.

Additionally, economic growth and rising disposable incomes in many countries within the Asia-Pacific region such as China and India have contributed to the growth of the pet care industry with higher spending power, pet owners are more willing to invest in the well-being of their pets, including pain management. This increased affordability and willingness to spend on veterinary products further drives market growth.

Furthermore, the rest of the world's veterinary pain management market is divided into the Middle East, Africa, and Latin America. The major factors driving the growth of veterinary pain management market in the region are the owing to the presence of countries such as Egypt and Saudi Arabia.

Veterinary pain management experienced a decline in the Covid-19 period as veterinary visits are limited. Therefore, companies started implementing various strategies to connect customers and veterinarians for integrated purchasing experience. Thus, this is expected to lead to stabilization in the veterinary pain management market in the forecast period.

Key Findings of the Study

• The global veterinary pain management market is expected to reach USD 3.70 billion by 2032, at a CAGR of 6.42% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market, owing to the presence of rapidly developing economies, and increasing healthcare expenditure in the Asia-Pacific region.


• Based on product, the medication segment was attributed to holding the largest market in 2022.


• Boehringer Ingelheim (Ingelheim am Rhein, Germany), Vetoquinol (Lure, France), Ceva Animal Health, LLC (Libourne, France), Chanelle Pharma (Galway, Ireland), Elanco (Indiana, US), Dechra Pharmaceuticals PLC (Northwich, UK), Zoetis (New Jersey, US), Merck & Co., Inc. (New Jersey, US), Assisi Animal Health (New Mexico, US), Eltech K-Laser (Treviso, Italy) are the key market players.